MEAGAN DAMERON: Open Payments
NPI 1215584784 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 73 payments from 15 companies in 2025. Trend: 2023 $543 · 2024 $1,601 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $336 |
| AstraZeneca Pharmaceuticals LP | 7 | $303 |
| Kestra Medical Technology Services, Inc. | 21 | $196 |
| Novo Nordisk Inc | 6 | $115 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| BridgeBio Pharma, Inc. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| ABIOMED | 2 | $47 |
| SCPHARMACEUTICALS INC. | 2 | $47 |
Products named: LEQVIO, WAINUA, Assure WCD, Wegovy, LifeVest, Kerendia, Attruby, JARDIANCE.
Industry payments across NC — which companies pay providers there.
